» Articles » PMID: 33466869

Identification of Molecular Basis for Objective Discrimination of Breast Cancer Cells (MCF-7) from Normal Human Mammary Epithelial Cells by Raman Microspectroscopy and Multivariate Curve Resolution Analysis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jan 20
PMID 33466869
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Raman spectroscopy (RS), a non-invasive and label-free method, has been suggested to improve accuracy of cytological and even histopathological diagnosis. To our knowledge, this novel technique tends to be employed without concrete knowledge of molecular changes in cells. Therefore, identification of Raman spectral markers for objective diagnosis is necessary for universal adoption of RS. As a model study, we investigated human mammary epithelial cells (HMEpC) and breast cancer cells (MCF-7) by RS and employed various multivariate analyses (MA) including principal components analysis (PCA), linear discriminant analysis (LDA), and support vector machine (SVM) to estimate diagnostic accuracy. Furthermore, to elucidate the underlying molecular changes in cancer cells, we utilized multivariate curve resolution analysis-alternating least squares (MCR-ALS) with non-negative constraints to extract physically meaningful spectra from complex cellular data. Unsupervised PCA and supervised MA, such as LDA and SVM, classified HMEpC and MCF-7 fairly well with high accuracy but without revealing molecular basis. Employing MCR-ALS analysis we identified five pure biomolecular spectra comprising DNA, proteins and three independent unsaturated lipid components. Relative abundance of lipid 1 seems to be strictly regulated between the two groups of cells and could be the basis for excellent discrimination by chemometrics-assisted RS. It was unambiguously assigned to linoleate rich glyceride and therefore serves as a Raman spectral marker for reliable diagnosis. This study successfully identified Raman spectral markers and demonstrated the potential of RS to become an excellent cytodiagnostic tool that can both accurately and objectively discriminates breast cancer from normal cells.

Citing Articles

Artificial Intelligence-Assisted Stimulated Raman Histology: New Frontiers in Vibrational Tissue Imaging.

Krishnan Nambudiri M, Sujadevi V, Poornachandran P, Murali Krishna C, Kanno T, Noothalapati H Cancers (Basel). 2024; 16(23).

PMID: 39682107 PMC: 11640088. DOI: 10.3390/cancers16233917.


Serum Raman spectroscopy: Unearthing the snapshot of distinct metabolic profile in patients with congenital heart defects (CHDs).

Joshi R, Goswami D, Saha P, Hole A, Mandhare P, Wadke R Heliyon. 2024; 10(16):e34575.

PMID: 39262980 PMC: 11388677. DOI: 10.1016/j.heliyon.2024.e34575.


The Emerging Role of Raman Spectroscopy as an Omics Approach for Metabolic Profiling and Biomarker Detection toward Precision Medicine.

Cutshaw G, Uthaman S, Hassan N, Kothadiya S, Wen X, Bardhan R Chem Rev. 2023; 123(13):8297-8346.

PMID: 37318957 PMC: 10626597. DOI: 10.1021/acs.chemrev.2c00897.


Simultaneous Imaging and Characterization of Polyunsaturated Fatty Acids, Carotenoids, and Microcrystalline Guanine in Single Cells with Linear and Nonlinear Raman Microspectroscopy.

Sasaki R, Toda S, Sakamoto T, Sakuradani E, Shigeto S J Phys Chem B. 2023; 127(12):2708-2718.

PMID: 36920390 PMC: 10068736. DOI: 10.1021/acs.jpcb.3c00302.


Multivariate Curve Resolution Alternating Least Squares Analysis of In Vivo Skin Raman Spectra.

Matveeva I, Bratchenko I, Khristoforova Y, Bratchenko L, Moryatov A, Kozlov S Sensors (Basel). 2022; 22(24).

PMID: 36559957 PMC: 9785721. DOI: 10.3390/s22249588.


References
1.
Laor D, Sade D, Shaham-Niv S, Zaguri D, Gartner M, Basavalingappa V . Fibril formation and therapeutic targeting of amyloid-like structures in a yeast model of adenine accumulation. Nat Commun. 2019; 10(1):62. PMC: 6325136. DOI: 10.1038/s41467-018-07966-5. View

2.
Cheng C, Geng F, Cheng X, Guo D . Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond). 2018; 38(1):27. PMC: 5993136. DOI: 10.1186/s40880-018-0301-4. View

3.
Wang D, DuBois R . Prostaglandins and cancer. Gut. 2005; 55(1):115-22. PMC: 1856377. DOI: 10.1136/gut.2004.047100. View

4.
You S, Tu H, Zhao Y, Liu Y, Chaney E, Marjanovic M . Raman Spectroscopic Analysis Reveals Abnormal Fatty Acid Composition in Tumor Micro- and Macroenvironments in Human Breast and Rat Mammary Cancer. Sci Rep. 2016; 6:32922. PMC: 5011773. DOI: 10.1038/srep32922. View

5.
Yi M, Li J, Chen S, Cai J, Ban Y, Peng Q . Emerging role of lipid metabolism alterations in Cancer stem cells. J Exp Clin Cancer Res. 2018; 37(1):118. PMC: 6003041. DOI: 10.1186/s13046-018-0784-5. View